Fertility-sparing management of early-stage endometrial cancer in reproductive age women: current treatment outcomes and future directions
- PMID: 34785521
- DOI: 10.1136/ijgc-2021-003192
Fertility-sparing management of early-stage endometrial cancer in reproductive age women: current treatment outcomes and future directions
Keywords: endometrial neoplasms; endometrium.
Conflict of interest statement
Competing interests: AO reports grants, personal fees, and other funding from SurgicalPerformance Pty, and grants from Medtronic, not directly related to the subject of this manuscript. AO reports consultancy fees from Baxter Healthcare Australia and New Zealand and AstraZeneca Australia, not directly related to the subject of this manuscript. In addition, AO has a trademark licensed to SurgicalPerformance Pty.
Comment on
-
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis.Int J Gynecol Cancer. 2021 Dec;31(12):1499-1505. doi: 10.1136/ijgc-2021-002699. Epub 2021 Nov 16. Int J Gynecol Cancer. 2021. PMID: 34785524
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
